Article Details

Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Phase 2 Head and Neck ...

Retrieved on: 2021-04-19 09:56:15

Tags for this article:

Click the tags to see associated articles and topics

Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Phase 2 Head and Neck .... View article details on hiswai:

Excerpt

... to harness the power of the immune system to combat cancer, today announced the initiation of dosing in a Phase 2 proof-of-concept trial in patients ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo